IF analysis of immunocytochemical section of NIH/3T3 cells treated with Anisomycin using anti-Phospho-JNK1/2/3 (T183+T183+T221) antibody (MP02608) Phospho-JNK1/2/3 (T183+T183+T221) was detected in immunocytochemical section. Enzyme antigen retrieval was performed using IHC enzyme antigen retrieval reagent (AR0022) for 15 mins. The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 2μg/mL rabbit anti-Phospho-JNK1/2/3 (T183+T183+T221) Antibody (MP02608) overnight at 4 °
Anti-Phospho-JNK1/2/3 (T183+T183+T221) MAPK8 Monoclonal Antibody
MP02608
ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetMAPK8
Overview
- SupplierBoster Bio
- Product NameAnti-Phospho-JNK1/2/3 (T183+T183+T221) Monoclonal Antibody
- Delivery Days Customer9
- ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDEAG-13
- FormulationLiquid
- Gene ID5599
- Target nameMAPK8
- Target descriptionmitogen-activated protein kinase 8
- Target synonymsc-Jun N-terminal kinase 1; JNK; JNK1; JNK1A2; JNK21B1/2; JNK-46; JUN N-terminal kinase; MAP kinase 8; mitogen-activated protein kinase 8; PRKM8; SAPK1; SAPK1c; stress-activated protein kinase 1; stress-activated protein kinase 1c
- HostRabbit
- IsotypeIgG
- Modification TypePhosphorylated
- Protein IDP45983
- Protein NameMitogen-activated protein kinase 8
- Scientific DescriptionBoster Bio Anti-Phospho-JNK1/2/3 (T183+T183+T221) MAPK8 Monoclonal Antibody catalog # MP02608. Tested in WB, IHC, ICC/IF, IP, Flow Cytometry applications. This antibody reacts with Human, Mouse, Rat.
- ReactivityHuman, Mouse, Rat
- Storage Instruction-20°C
- UNSPSC12352203
References
- SLC34A2 Up-regulation And SLC4A4 Down-regulation Correlates With Invasion, Metastasis, And The MAPK Signaling Pathway In Papillary Thyroid Carcinomas. Huang F et al., 2021, J CancerRead more
- Mini-peptide RPL41 attenuated retinal neovascularization by inducing degradation of ATF4 in oxygen-induced retinopathy mice. Geng W et al., 2018 Aug 15, Exp Cell ResRead more